MEDP 241018 360.00C (MEDP241018C360000) Stock Options, News & Quotes

2.95
+0.11+3.87%

15min DelayClose Oct 11 15:59 ET

2.95High2.95Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Moomoo AI

Mar 22 08:59

Investors expect Medpace Holdings to outperform the market, hence its high P/E ratio. Strong future growth anticipation makes investors pay more for the stock, supporting the share price.

The Price Is Right For Medpace Holdings, Inc. (NASDAQ:MEDP)

Moomoo AI

Feb 21 05:52

Medpace Holdings' robust conversion of profit to free cash flow is promising. Its underlying earnings potential may even surpass the statutory profit. Its earnings per share have seen a remarkable growth over the past three years.

Medpace Holdings' (NASDAQ:MEDP) Earnings Seem To Be Promising

Moomoo AI

Feb 19 08:35

Medpace Holdings' market sentiment remains steady, mirroring EPS growth. The stock's recent performance shows improvement, with a 90% shareholder return over the last year, surpassing the five-year TSR of 41% per year. The strong share price momentum suggests a closer look at the stock may be worthwhile.

Medpace Holdings (NASDAQ:MEDP) Jumps 21% This Week, Though Earnings Growth Is Still Tracking Behind Five-year Shareholder Returns

Moomoo AI

Dec 20, 2023 07:21

Medpace's high P/E is backed by its forecast growth being higher than the wider market. Investors are quite confident in the company's future earnings and seem willing to pay more for the stock, suggesting a bullish outlook.

Medpace Holdings, Inc.'s (NASDAQ:MEDP) Earnings Haven't Escaped The Attention Of Investors

Moomoo AI

Nov 18, 2023 06:42

Insider selling at current price (US$274) is less worrying, but there were no purchases over the past year to boost confidence. A high level of insider ownership often implies interests of all shareholders are considered, though recent history of share sales triggers some hesitation.

This Insider Has Just Sold Shares In Medpace Holdings